Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Beijing Biostar Pharmaceuticals Co Days Inventory?
Beijing Biostar Pharmaceuticals CoHKSE:02563 +4.41%9 Days Inventory is 4,987.96 as of Dec. 2025, which is 319% above its 10-year median of 1,190.76. GuruFocus rates HKSE:02563 with a GF Score™ of 9/100. The stock has 4 warning signs investors should review. Among 637 Biotechnology companies, Beijing Biostar Pharmaceuticals Co ranks worse than 97.65% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Beijing Biostar Pharmaceuticals Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beijing Biostar Pharmaceuticals Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 2.31.
Beijing Biostar Pharmaceuticals Co (HKSE:02563) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Beijing Biostar Pharmaceuticals Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beijing Biostar Pharmaceuticals Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Beijing Biostar Pharmaceuticals Co Days Inventory Related Terms
Beijing Biostar Pharmaceuticals Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Biostar Pharmaceuticals Co Days Inventory Chart
Beijing Biostar Pharmaceuticals Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Days Inventory
1,270.04
543.79
1,111.47
5,310.43
Beijing Biostar Pharmaceuticals Co Semi-Annual Data
HKSE:02563 vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Beijing Biostar Pharmaceuticals Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Biostar Pharmaceuticals Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Biostar Pharmaceuticals Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Beijing Biostar Pharmaceuticals Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Biostar Pharmaceuticals Co (HKSE:02563) has a Days Inventory of 4,987.96 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beijing Biostar Pharmaceuticals Co and its competitors. This is 319% above median its historical median of 1,190.76. Over the past decade, Beijing Biostar Pharmaceuticals Co's Days Inventory has ranged from 543.79 to 5,437.07. According to the industry distribution chart, Beijing Biostar Pharmaceuticals Co ranks #622 out of 637 companies in the Biotechnology industry, placing it in the top 97.6%.
Is Beijing Biostar Pharmaceuticals Co's Days Inventory too high?
Beijing Biostar Pharmaceuticals Co's current Days Inventory of 4,987.96 is 319% above median its 10-year median of 1,190.76. Over the past 10 years, this metric has ranged from a low of 543.79 to a high of 5,437.07. The Biotechnology industry median Days Inventory is 181.41. Beijing Biostar Pharmaceuticals Co's value of 4,987.96 is 2649.6% above this industry median. Based on the distribution chart, Beijing Biostar Pharmaceuticals Co ranks #622 out of 637 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Beijing Biostar Pharmaceuticals Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Biostar Pharmaceuticals Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Biostar Pharmaceuticals Co ranks #622 out of 637 companies for Days Inventory. This places Beijing Biostar Pharmaceuticals Co in the lower half of its industry. The industry median Days Inventory is 181.41. Beijing Biostar Pharmaceuticals Co's value of 4,987.96 is 2649.6% above this benchmark. Historically, Beijing Biostar Pharmaceuticals Co's own Days Inventory has ranged from 543.79 to 5,437.07 over the past decade. While the company's 10-year median is 1,190.76 vs. the industry median of 181.41, Beijing Biostar Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 181.41, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Biostar Pharmaceuticals Co's current Days Inventory of 4,987.96 is 2649.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beijing Biostar Pharmaceuticals Co and its competitors. For the Biotechnology industry, the median Days Inventory is 181.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Biostar Pharmaceuticals Co's current Days Inventory is 4,987.96, which is 319% above median its own 10-year median of 1,190.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Biostar Pharmaceuticals Co stock overvalued right now?
Beijing Biostar Pharmaceuticals Co (HKSE:02563) has a current Days Inventory of 4,987.96. The current Days Inventory is 4,987.96, which is 319% above median its 10-year median of 1,190.76 and 2649.6% above the Biotechnology industry median of 181.41. Beijing Biostar Pharmaceuticals Co's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Beijing Biostar Pharmaceuticals Co (HKSE:02563), the current Days Inventory is 4,987.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beijing Biostar Pharmaceuticals Co Ltd is a synthetic biology-driven biopharmaceutical company committed to developing drugs in oncology. It has developed three core technology platforms that focus on the R&D of microbial metabolite new drugs. Its Core Product and 16 out of 19 product candidates are based on a single active pharmaceutical ingredient, namely, Utidelone, which was represented in three formulations of its product portfolio. The company's current clinical trials and programs of the Core Product and product candidates cover indications of advanced breast cancer, advanced non-small cell lung cancer, neoadjuvant for breast cancer, gastric cancer, esophageal cancer, breast cancer brain metastasis, lung cancer brain metastasis, glioblastoma, and other solid tumors.
9GF Score
Get the complete analysis for HKSE:02563
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02563 has been successfully added to your 
